- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x GLU: GLUTAMIC ACID(Non-covalent)
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NAP.2: 28 residues within 4Å:- Chain A: G.39, I.40, A.41, S.45, I.46, R.66, K.67, S.70, I.91, D.92, V.93, S.119, I.120, A.121, I.146, T.171, T.172, Y.173, K.190, A.216, G.217, P.218, I.219, T.221, L.222, S.223, F.230
- Ligands: PV4.3
25 PLIP interactions:25 interactions with chain A- Hydrophobic interactions: A:I.46, A:Y.173, A:Y.173, A:A.216
- Hydrogen bonds: A:G.39, A:I.46, A:R.66, A:R.66, A:K.67, A:S.70, A:D.92, A:D.92, A:V.93, A:I.120, A:A.121, A:K.190, A:I.219, A:I.219, A:S.223, A:S.223
- Water bridges: A:A.47, A:S.119, A:T.171
- Salt bridges: A:R.66, A:K.67
NAP.5: 28 residues within 4Å:- Chain B: G.39, I.40, A.41, S.45, I.46, R.66, K.67, S.70, I.91, D.92, V.93, Q.94, S.119, I.120, A.121, I.146, T.171, T.172, Y.173, K.190, A.216, G.217, P.218, I.219, T.221, L.222, S.223
- Ligands: PV4.6
23 PLIP interactions:23 interactions with chain B- Hydrophobic interactions: B:I.46, B:Y.173, B:A.216
- Hydrogen bonds: B:G.39, B:I.46, B:R.66, B:R.66, B:K.67, B:S.70, B:D.92, B:V.93, B:I.120, B:A.121, B:K.190, B:I.219, B:I.219, B:S.223
- Water bridges: B:S.119, B:S.119, B:T.171, B:L.222
- Salt bridges: B:R.66, B:K.67
NAP.8: 27 residues within 4Å:- Chain C: G.39, I.40, A.41, S.45, I.46, R.66, K.67, S.70, I.91, D.92, V.93, S.119, I.120, A.121, I.146, T.171, T.172, Y.173, K.190, A.216, G.217, P.218, I.219, T.221, L.222, S.223
- Ligands: PV4.9
25 PLIP interactions:25 interactions with chain C- Hydrophobic interactions: C:I.46, C:Y.173, C:A.216
- Hydrogen bonds: C:G.39, C:I.46, C:R.66, C:R.66, C:K.67, C:S.70, C:D.92, C:V.93, C:I.120, C:A.121, C:K.190, C:I.219, C:I.219, C:T.221, C:S.223
- Water bridges: C:N.42, C:A.47, C:T.171, C:L.222
- Salt bridges: C:R.66, C:K.67
- pi-Cation interactions: C:R.66
NAP.10: 29 residues within 4Å:- Chain D: G.39, I.40, A.41, S.45, I.46, R.66, K.67, S.70, I.91, D.92, V.93, S.119, I.120, A.121, F.122, I.146, T.171, T.172, Y.173, K.190, A.216, G.217, P.218, I.219, T.221, L.222, S.223, A.224
- Ligands: PV4.11
26 PLIP interactions:26 interactions with chain D- Hydrophobic interactions: D:I.46, D:Y.173, D:A.216
- Hydrogen bonds: D:G.39, D:I.46, D:R.66, D:R.66, D:K.67, D:S.70, D:D.92, D:V.93, D:I.120, D:A.121, D:K.190, D:I.219, D:I.219, D:T.221, D:T.221, D:S.223, D:S.223
- Water bridges: D:N.42, D:A.47, D:I.120, D:L.222
- Salt bridges: D:R.66, D:K.67
- 4 x PV4: 2-phenoxy-5-propyl-phenol(Non-covalent)
PV4.3: 13 residues within 4Å:- Chain A: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, I.233
- Ligands: NAP.2
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:A.121, A:L.128, A:Y.173, A:Y.173, A:Y.173, A:Y.183, A:A.224, A:V.227, A:V.227, A:I.233
- Hydrogen bonds: A:Y.183
PV4.6: 12 residues within 4Å:- Chain B: A.121, F.122, A.123, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230
- Ligands: NAP.5
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:A.121, B:Y.173, B:Y.183, B:V.227, B:F.230
- Hydrogen bonds: B:Y.183
PV4.9: 14 residues within 4Å:- Chain C: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230, I.233
- Ligands: NAP.8
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:A.121, C:L.128, C:Y.183, C:A.224, C:V.227, C:F.230, C:F.230, C:I.233
PV4.11: 14 residues within 4Å:- Chain D: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230, I.233
- Ligands: NAP.10
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:L.128, D:Y.173, D:Y.183, D:Y.183, D:A.224, D:V.227, D:F.230, D:I.233
- pi-Stacking: D:Y.173
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chang, A. et al., Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the S. Aureus Fabi Enzyme-Product Complex. Biochemistry (2013)
- Release Date
- 2013-06-05
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x GLU: GLUTAMIC ACID(Non-covalent)
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x PV4: 2-phenoxy-5-propyl-phenol(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chang, A. et al., Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the S. Aureus Fabi Enzyme-Product Complex. Biochemistry (2013)
- Release Date
- 2013-06-05
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H